Competitive: Origin Sciences: Origin Sciences is a start-up biotechnology company based in Granta Park, just south of Cambridge. We develop our own innovative medical devices, whic Cambridge, United Kingdom

Competitive: Origin Sciences: Origin Sciences is a start-up biotechnology company based in Granta Park, just south of Cambridge. We develop our own innovative medical devices, whic Cambridge, United Kingdom

Competitive: Genomics England: Company Description Genomics England partners with the NHS to provide whole genome sequencing diagnostics. We also equip researchers to find the caus Cambridge, United Kingdom

Funding Opportunity RFA-OH-25-002 from the NIH Guide for Grants and Contracts. Purpose. The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Education and Research Centers (ERCs) that are focused on graduate occupational safety and health (OSH) training.

Notice NOT-CA-24-110 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-24-035 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain or establish Network Group Integrated Translational Science Centers for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Integrated Translational Science Centers will provide support for leadership and expertise to facilitate incorporating translational science into Network Group clinical trials, including the conduct of pilot projects to collect preliminary translational data (but not the conduct of a clinical trial as defined by NIH).

Funding Opportunity RFA-CA-24-034 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications to maintain a Network Radiotherapy and Imaging Core Services Center for the NCI National Clinical Trials Network (NCTN) that provides scientific and technical expertise for incorporating integrated quality assurance and image data management for applicable NCTN clinical trials that involve interventions with radiotherapy and/or imaging modalities. In addition, the Center will have the capacity to provide similar services for other approved NCI-supported clinical trials network programs (e.g., the NCI/DCTD early phase clinical trial network program and the NCI/DCP NCI Community Oncology Research Program).

Funding Opportunity RFA-CA-24-032 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain a Canadian Collaborating Clinical Trials Network for the NCI National Clinical Trials Network (NCTN). The NCTN Canadian Collaborating Clinical Trials Network will be a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials and help provide regulatory expertise/oversight for the conduct of NCTN trials in Canada.

Funding Opportunity RFA-CA-24-030 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain a Network Group Operations Center for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Operations Centers will provide scientific leadership for developing and implementing multi-disciplinary, multi-institutional trials in a range of cancer types and special populations with specific scientific strategy and goals.

Notice NOT-DC-24-041 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-143 from the NIH Guide for Grants and Contracts

Notice NOT-DC-25-004 from the NIH Guide for Grants and Contracts

Notice NOT-HS-25-002 from the NIH Guide for Grants and Contracts

Notice NOT-LM-24-005 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-088 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-25-020 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) seeks to support research aimed at holistic understanding of inter-individual or between-person differences in human pain conditions, focusing on Whole Person Health and enhancing pain treatment and management strategies towards personalized pain medicine. The goal of this NOFO is to support studies that focus on the collection of clinical and/or preclinical data to enable evidence-based modeling and understanding of inter-individual differences and/or heterogeneity of pain occurring with use of pain therapy/management, or with conditions such as a second pain condition, a comorbid health condition, a comorbid mental health condition, or conditions of use / misuse of opioids, alcohol or other substances. Applicants are encouraged to develop and implement novel, multidisciplinary research approaches, and include investigators with complementary expertise to fulfill the project and program goals. Input from patients and caregivers on the goals of the project is highly encouraged. Rigorous data-driven and evidence-based research approaches supported under this NOFO are expected to provide better understanding of biological and/or biopsychosocial underpinnings of inter-individual differences, heterogeneity, and stratification of persons with lived pain experience, which would accelerate the development of evidence-based solutions toward precision pain medicine.

Negotiable: Oxford Nanopore Technologies: Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and a commercial presence in many England

Negotiable: Oxford Nanopore Technologies: Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and a commercial presence in many England

Notice NOT-DC-25-001 from the NIH Guide for Grants and Contracts

From £43,210 per annum with benefits, subject to skills and experience: The Francis Crick Institute: Dr Bishop is seeking a talented and motivated postdoc to study the function of the HIV Vpr protein during HIV infection. London (Greater)